Anoikis-Associated Signatures Predict Prognosis and Immune Response in Bladder Cancer

References

• Sung H , FerlayJ , SiegelRLet al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.71(3), 209–249 (2021).
   PubMed Web of Science ®Google Scholar
• Patel VG , OhWK , GalskyMD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J. Clin.70(5), 404–423 (2020).
   PubMed Web of Science ®Google Scholar
• Tran L , XiaoJF , AgarwalN , DuexJE , TheodorescuD. Advances in bladder cancer biology and therapy. Nat. Rev. Cancer21(2), 104–121 (2021).
   PubMed Web of Science ®Google Scholar
• Lenis AT , LecPM , ChamieK , MshsMD. Bladder cancer: a review. JAMA324(19), 1980–1991 (2020).
   PubMed Web of Science ®Google Scholar
• Galluzzi L , VitaleI , AaronsonSAet al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ.25(3), 486–541 (2018).
   PubMed Web of Science ®Google Scholar
• Raeisi M , ZehtabiM , VelaeiKet al. Anoikis in cancer: the role of lipid signaling. Cell Biol. Int.46(11), 1717–1728 (2022).
   PubMed Web of Science ®Google Scholar
• Han HJ , SungJY , KimSHet al. Fibronectin regulates anoikis resistance via cell aggregate formation. Cancer Lett.508, 59–72 (2021).
   PubMed Web of Science ®Google Scholar
• D’amato NC , RogersTJ , GordonMAet al. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer. Cancer Res.75(21), 4651–4664 (2015).
   PubMed Web of Science ®Google Scholar
• Mihalopoulos M , DoveyZ , ArcherMet al. Repurposing of α1-adrenoceptor antagonists: impact in renal cancer. Cancers (Basel)12(9), (2020).
   PubMed Web of Science ®Google Scholar
• Cao L , HanL , ZhangZet al. Involvement of anoikis-resistance in the metastasis of hepatoma cells. Exp. Cell Res.315(7), 1148–1156 (2009).
   PubMed Web of Science ®Google Scholar
• Brunquell C , BiliranH , JenningsS , IrelandSK , ChenR , RuoslahtiE. TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells. Mol. Cancer Res.10(11), 1482–1495 (2012).
   PubMed Web of Science ®Google Scholar
• Douma S , Van LaarT , ZevenhovenJet al. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature430(7003), 1034–1039 (2004).
   PubMed Web of Science ®Google Scholar
• Khan SU , FatimaK , MalikF. Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis. Clin. Exp. Metastasis39(5), 715–726 (2022).
   PubMed Web of Science ®Google Scholar
• Xiao Y , DongY , YuTet al. Characterization of the immune related lncRNAs in bladder cancer to aid immunotherapy. Front. Immunol.13, 941189 (2022).
   PubMedGoogle Scholar
• Wang Y , YangX , SunXet al. Bone marrow infiltrated Lnc-INSR induced suppressive immune microenvironment in pediatric acute lymphoblastic leukemia. Cell Death Dis.9(10), 1043 (2018).
   PubMed Web of Science ®Google Scholar
• Brahic M , BureauJF , MichielsT. The genetics of the persistent infection and demyelinating disease caused by Theiler’s virus. Annu. Rev. Microbiol.59, 279–298 (2005).
   PubMed Web of Science ®Google Scholar
• Sharma S , FindlayGM , BandukwalaHSet al. Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA–protein scaffold complex. Proc. Natl. Acad. Sci. U S A108(28), 11381–11386 (2011).
   PubMed Web of Science ®Google Scholar
• Balar AV , GalskyMD , RosenbergJEet al. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial. Lancet389(10064), 67–76 (2017).
   PubMed Web of Science ®Google Scholar
• Ritchie ME , PhipsonB , WuDet al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucl. Acids Res.43(7), e47 (2015).
   PubMed Web of Science ®Google Scholar
• Gao Y , LinT , PanJet al. Fuzzy sparse deviation regularized robust principal component analysis. IEEE Trans. Image Process31, 5645–5660 (2022).
   PubMed Web of Science ®Google Scholar
• Yoshihara K , ShahmoradgoliM , MartínezEet al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun.4, 2612 (2013).
   PubMed Web of Science ®Google Scholar
• Jiang P , GuS , PanDet al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med.24(10), 1550–1558 (2018).
   PubMed Web of Science ®Google Scholar
• Lai H , ChengX , LiuQet al. Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer. Int. J. Cancer149(12), 2099–2115 (2021).
   PubMed Web of Science ®Google Scholar
• Wolf FA , AngererP , TheisFJ. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol.19(1), 15 (2018).
   PubMed Web of Science ®Google Scholar
• Yang W , SoaresJ , GreningerPet al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucl. Acids Res.41(Database issue), D955–961 (2013).
   PubMedGoogle Scholar
• Yin J , WangJ , ZhangXet al. A missing piece of the puzzle in pulmonary fibrosis: anoikis resistance promotes fibroblast activation. Cell Biosci.12(1), 21 (2022).
   PubMed Web of Science ®Google Scholar
• Zhong X , RescorlaFJ. Cell surface adhesion molecules and adhesion-initiated signaling: understanding of anoikis resistance mechanisms and therapeutic opportunities. Cell Signal.24(2), 393–401 (2012).
   PubMed Web of Science ®Google Scholar
• Ploussard G , DaneshmandS , EfstathiouJAet al. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review. Eur. Urol.66(1), 120–137 (2014).
   PubMed Web of Science ®Google Scholar
• Xu W , AnwaierA , MaCet al. Multi-omics reveals novel prognostic implication of SRC protein expression in bladder cancer and its correlation with immunotherapy response. Ann. Med.53(1), 596–610 (2021).
   PubMed Web of Science ®Google Scholar
• Zhou Z , ZhangZ , ChenHet al. SBSN drives bladder cancer metastasis via EGFR/SRC/STAT3 signalling. Br. J. Cancer127(2), 211–222 (2022).
   PubMed Web of Science ®Google Scholar
• Chevalier MF , TrabanelliS , RacleJet al. ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence. J. Clin. Invest.127(8), 2916–2929 (2017).
   PubMed Web of Science ®Google Scholar
• Pichler R , GruenbacherG , CuligZet al. Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer. Cancer Immunol. Immunother.66(4), 427–440 (2017).
   PubMed Web of Science ®Google Scholar
• Biot C , RentschCA , GsponerJRet al. Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. Sci. Transl. Med.4(137), 137ra172 (2012).
   Web of Science ®Google Scholar
• Antonelli AC , BinyaminA , HohlTM , GlickmanMS , Redelman-SidiG. Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling. Proc. Natl. Acad. Sci. U S A117(31), 18627–18637 (2020).
   PubMed Web of Science ®Google Scholar
• Honsho M , OkumotoK , TamuraS , FujikiY. Peroxisome biogenesis disorders. Adv. Exp. Med. Biol.1299, 45–54 (2020).
   PubMed Web of Science ®Google Scholar
• Farré JC , MahalingamSS , ProiettoM , SubramaniS. Peroxisome biogenesis, membrane contact sites, and quality control. EMBO Rep.20(1), (2019).
   PubMed Web of Science ®Google Scholar
• Johnstone RW , RuefliAA , LoweSW. Apoptosis: a link between cancer genetics and chemotherapy. Cell108(2), 153–164 (2002).
   PubMed Web of Science ®Google Scholar
• De Jong FC , RuttenVC , ZuiverloonTCM , TheodorescuD. Improving anti-PD-1/PD-L1 therapy for localized bladder cancer. Int. J. Mol. Sci.22(6), (2021).
   Web of Science ®Google Scholar
• Wang L , SaciA , SzaboPMet al. EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer. Nat. Commun.9(1), 3503 (2018).
   PubMed Web of Science ®Google Scholar
• Schneider AK , ChevalierMF , DerréL. The multifaceted immune regulation of bladder cancer. Nat. Rev. Urol.16(10), 613–630 (2019).
   PubMed Web of Science ®Google Scholar
• Yang J , LiaoQ , PriceMet al. Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation. Transl. Oncol.16, 101318 (2022).
   PubMed Web of Science ®Google Scholar
• Zuo Y , XuX , ChenM , QiL. The oncogenic role of the cerebral endothelial cell adhesion molecule (CERCAM) in bladder cancer cells in vitro and in vivo. Cancer Med.10(13), 4437–4450 (2021).
   PubMed Web of Science ®Google Scholar
• Du J , LiZ , LiQZet al. Enoyl coenzyme a hydratase domain-containing 2, a potential novel regulator of myocardial ischemia injury. J. Am. Heart Assoc.2(5), e000233 (2013).
   PubMed Web of Science ®Google Scholar
• Owens TW , ValentijnAJ , UptonJPet al. Apoptosis commitment and activation of mitochondrial Bax during anoikis is regulated by p38MAPK. Cell Death Differ.16(11), 1551–1562 (2009).
   PubMed Web of Science ®Google Scholar
• Liu Z , LiH , DerouetMet al. Oncogenic Ras inhibits anoikis of intestinal epithelial cells by preventing the release of a mitochondrial pro-apoptotic protein Omi/HtrA2 into the cytoplasm. J. Biol. Chem.281(21), 14738–14747 (2006).
   PubMed Web of Science ®Google Scholar
• Liu J , CuiJ , ZhaoSet al. Ferroptosis-related long noncoding RNAs have excellent predictive ability for multiomic characteristics of bladder cancer. Oxid. Med. Cell Longev.2022, 9316847 (2022).
   PubMed Web of Science ®Google Scholar